한글목차

세계 항혈전제/항응고제 시장 규모는 2023년 316억 달러에서 예측 기간 동안 7.9%의 CAGR을 나타내고, 2028년 462억 달러 규모로 성장할 것으로 예상됩니다.

트롬빈 억제제 부문은 2023년 246억 달러에서 2028년 363억 달러 규모로 성장할 것으로 예상되며, 같은 기간 동안 8.1%의 CAGR을 나타낼 것으로 전망됩니다. 항혈소판제 부문은 2023년 40억 달러 규모에서 2028년 58억 달러 규모로 CAGR 7.8%로 성장할 것으로 예상됩니다.

세계의 항혈전제/항응고제 시장을 조사했으며, 시장 및 기술 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 기술 및 특허 동향, ESG 전개, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약 및 하이라이트

제3장 시장 개요

• 심혈관질환 개요
• 관상동맥 질환
• 죽상동맥경화증
• 협심증
• 급성 심근경색
• 의료 관리
• 라이프스타일 변화
• 식사 수정
• 금연
• 의약품
• 항응고제 및 항혈소판제
• 주요 촉진요인
• CVD 경감을 목적으로 한 응고인자
• 심혈관질환 세계 부담
• 심혈관질환 세계의 경제적 부담
• 2022년 주요 의약품 판매 실적

제4장 세계의 항응고제 시장

• 개요
• 제품
• 저분자량 헤파린
• 경구 항응고제(비타민 K 길항제)
• 세계의 항응고제 시장 예측

제5장 세계의 항혈소판제 시장

• 개요
• 제품
• 경구 항혈소판제
• 세계의 항혈소판제 시장 예측

제6장 세계의 트롬빈 저해제 시장

• 개요
• 제품
• 직접적 트롬빈 저해제
• 혈전용해 제
• 직접 제Xa인자 저해제
• 세계의 트롬빈 저해제 시장 예측

제7장 세계의 항혈전제/항응고제 시장 : 지역별

• 개요
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제8장 항혈전제/항응고제 시장의 지속가능성 : ESG 관점

• ESG : 서론
• 항혈전제/항응고제 시장 지속가능성 : ESG 관점으로부터
• ESG상의 주요 문제
• ESG에 대한 소비자 의식
• 업계의 ESG 퍼포먼스 분석
• 사례 연구
• BCC의 결론

제9장 임상시험과 특허 상황

• 임상시험 분석
• 특허 분석
• 특허 : 양수인별

제10장 인수합병(M&A) 및 벤처 자금 조달 전망

• 인수합병(M&A)분석

제11장 경쟁 구도

제12장 기업 개요

• BAYER AG
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• BRISTOL MYERS SQUIBB
• DAIICHI SANKYO CO. LTD.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON SERVICES INC.
• MERCK & CO. INC.
• PFIZER INC.
• SANOFI

제13장 부록

영문목차

Highlights:

The global market for antithrombotic/anticoagulant drugs is estimated to grow from $31.6 billion in 2023 to reach $46.2 billion by 2028, at a compound annual growth rate (CAGR) of 7.9% from 2023 through 2028.

The global market for thrombin inhibitors is estimated to grow from $24.6 billion in 2023 to reach $36.3 billion by 2028, at a CAGR of 8.1% from 2023 through 2028.

The global market for antiplatelet drugs is estimated to grow from $4.0 billion in 2023 to reach $5.8 billion by 2028, at a CAGR of 7.8% from 2023 through 2028.

Report Scope:

This report discusses the implications of the trends mentioned above in the context of the current size and growth of the antithrombotic/anticoagulant drugs market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug categories and the country offers breakdowns of the antithrombotic/anticoagulant drugs market.

Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the antithrombotic/anticoagulant drugs market.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World. For market estimates, data are provided for 2022 as the base year, forecasted through 2023-2028.

Report Includes:

• 59 data tables and 35 additional tables
• Overview and an up-to-date analysis of the global markets for antithrombotic/anticoagulant drugs for the treatments of thrombotic (cardiovascular) disease
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Examination of the market potential for antithrombotic/anticoagulant drugs, and quantification of the global market for these drugs and its market segments and sub-segments over the next five years
• Estimate of the actual market size and revenue forecast for the market, and corresponding market share analysis based on product type, application and region
• In-depth information (facts and figures) pertaining to the market drivers, challenges, opportunities and prospects, as well as the technologies, regulatory scenarios and impact of COVID-19
• A look at the major vendors in the global market for antithrombotic/anticoagulant drugs, and analysis of the healthcare industry structure, including market shares and recent mergers and acquisitions (M&A) activity
• Review of key patent grants and a look at breakthrough innovations, novel products, upcoming trends and technologies, and emerging applications for cardiovascular treatments
• Insight into the importance of ESG in the worldwide market, with a look at consumer attitudes, risks and opportunities assessment, and ESG practices followed by manufacturers and service providers
• Identification of the major stakeholders, and analysis of the competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
• Profiles of the leading market players

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Report?
• Scope of Report
• Research Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Overview of Cardiovascular Disease
• Coronary Artery Disease
• Atherosclerosis
• Angina (Angina Pectoris)
• Acute Myocardial Infarction
• Medical Management
• Lifestyle Changes
• Diet Modification
• Smoking Cessation
• Pharmaceuticals
• Anticoagulants and Antiplatelet Drugs
• Major Drivers
• Coagulation Factors Targeted to Reduce CVD
• The Global Burden of Cardiovascular Disease
• 2030 Global Burden of Cardiovascular Disease
• The Global Economic Burden of Cardiovascular Disease
• Sales Performance of Major Drugs in 2022

Chapter 4 Global Market for Anticoagulant Drugs

• Overview
• Products
• Low Molecular Weight Heparin
• Oral Anticoagulants (Vitamin K Antagonists)
• Global Anticoagulant Drugs Market Forecast

Chapter 5 Global Market for Antiplatelet Drugs

• Overview
• Products
• Oral Antiplatelets
• Global Antiplatelet Drugs Market Forecast

Chapter 6 Global Market for Thrombin Inhibitors

• Overview
• Products
• Direct Thrombin Inhibitors
• Thrombolytic Agents
• Direct Factor Xa Inhibitors
• Global Thrombin Inhibitors Market Forecast

Chapter 7 Global Market for Antithrombotic/Anticoagulant Drugs by Region

• Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 8 Sustainability in the Market for Antithrombotic/Anticoagulant Drugs: An ESG Perspective

• Introduction to ESG
• Sustainability in Market for Antithrombotic/Anticoagulant Drugs: An ESG Perspective
• Key ESG Issues
• Consumer Attitudes Towards ESG
• Industry ESG Performance Analysis
• Case Study
• Concluding Remarks from BCC

Chapter 9 Clinical Trials and Patent Landscape

• Clinical Trials Analysis
• Patent Analysis
• Patent by Assignee

Chapter 10 M&A and Venture Funding Outlook

• M&A Analysis

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

• BAYER AG
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• BRISTOL MYERS SQUIBB
• DAIICHI SANKYO CO. LTD.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON SERVICES INC.
• MERCK & CO. INC.
• PFIZER INC.
• SANOFI

Chapter 13 Appendix

• Government Regulatory Agencies and Professional Organizations